Zacks Company Profile for Strata Skin Sciences, Inc. (SSKN : NSDQ) |
|
|
|
Company Description |
Strata Skin Sciences, Inc. is a medical technology company which focused on the dermatology market. Its products include the XTRAC laser(R) and VTRAC(R) excimer lamp systems for treatment of psoriasis, vitiligo and other skin conditions as well as the MelaFind (R) system used for identification and management of melanoma skin cancer. Strata Skin Sciences, Inc., formerly known as MELA Sciences, Inc., is based in Horsham, Pennsylvania.
Number of Employees: 106 |
|
|
|
Price / Volume Information |
Yesterday's Closing Price: $2.33 |
Daily Weekly Monthly
 |
20 Day Moving Average: 13,305 shares |
Shares Outstanding: 4.17 (millions) |
Market Capitalization: $9.72 (millions) |
Beta: 0.69 |
52 Week High: $3.80 |
52 Week Low: $2.10 |
Short Interest Ratio: |
|
% Price Change |
% Price Change Relative to S&P 500 |
4 Week |
-4.12% |
-8.38% |
12 Week |
-7.91% |
-21.34% |
Year To Date |
-19.93% |
-25.00% |
|
|
|
|
|
|
|
General Corporate Information |
Officers
Dolev Rafaeli - Chief Executive Officer;President and Director
Uri Geiger - Chairperson
John Gillings - Chief Accounting Officer
Samuel Rubinstein - Director
Christina Allgeier - Director
|
|
Peer Information
Strata Skin Sciences, Inc. (HLIS)
Strata Skin Sciences, Inc. (AZTA)
Strata Skin Sciences, Inc. (APYI)
Strata Skin Sciences, Inc. (RNVA)
Strata Skin Sciences, Inc. (HMSY)
Strata Skin Sciences, Inc. (LRSI)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MEDICAL INFO SYS
Sector: Medical
CUSIP: 86272A305
SIC: 3841
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/13/25
|
|
Share - Related Items
Shares Outstanding: 4.17
Most Recent Split Date: 6.00 (0.10:1)
Beta: 0.69
Market Capitalization: $9.72 (millions)
|
|
|
|
|
|
EPS Information |
Dividend Information |
Analyst Coverage: No |
Dividend Yield: 0.00% |
Current Fiscal Quarter EPS Consensus Estimate: $ |
Indicated Annual Dividend: $0.00 |
Current Fiscal Year EPS Consensus Estimate: $-1.18 |
Payout Ratio: |
Number of Estimates in the Fiscal Year Consensus: 1.00 |
Change In Payout Ratio: |
Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
Next EPS Report Date: 08/13/25 |
|
|
|
|